Who owns GT BIOPHARMA INC?
- CUSIP Number: 36254l209
Tip: Access positions for across all investors
Analyze quarterly positions in Gt Biopharma with up to 7 years of data, all consolidated into one spreadsheet
Download as csv Download as ExcelTop investors of Gt Biopharma stock
Who bought or sold GT BIOPHARMA INC this quarter?
Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
---|---|---|---|---|---|
Vanguard Group | 1.1M | $277k | 0% | Dec 2023 |
|
Bank Of Montreal | 596k | $170k | 0% | Dec 2023 |
|
Wells Fargo & Company | 301k | $77k | 0% | Dec 2023 |
|
Atria Wealth Solutions | 99k | $25k | 11% | Dec 2023 |
|
Bank of New York Mellon | 95k | $24k | 0% | Dec 2023 |
|
Millennium Management | 66k | $17k | -25% | Dec 2023 |
|
Citadel Advisors | 58k | $15k | 100% | Dec 2023 |
|
Two Sigma Securities | 37k | $9.5k | 20% | Dec 2023 |
|
Hrt Financial | 34k | $8.0k | 100% | Dec 2023 |
|
Goldman Sachs Group | 23k | $5.8k | 119% | Dec 2023 |
|
Moss Adams Wealth Advisors | 20k | $5.1k | 0% | Dec 2023 |
|
Jane Street | 19k | $4.9k | 100% | Dec 2023 |
|
UBS Group | 15k | $3.5k | 67% | Dec 2023 |
|
Commonwealth Equity Services | 10k | $3.0k | 0% | Dec 2023 |
|
Royal Bank of Canada | 2.2k | $0 | -10% | Dec 2023 |
|
Bank of America Corporation | 1.1k | $0 | 111% | Dec 2023 |
|
Advisor Group Holdings | 1.0k | $253.233000 | -20% | Dec 2023 |
|
Simplex Trading | 304.00 | $0 | -33% | Dec 2023 |
|
Blue Bell Private Wealth Management | 300.00 | $77.010000 | 0% | Dec 2023 |
|
Retirement Group | 44.00 | $11.000000 | 0% | Dec 2023 |
|
Jpmorgan Chase & Co | 16.00 | $4.000000 | -73% | Dec 2023 |
|
Who sold out of Gt Biopharma?
Fund or Company Name | Date Sold | Shares Held | Valued At |
---|---|---|---|
Baskin Financial Services | Sep 2023 | 151k | $36k |
Compagnie Lombard, Odier SCA | Sep 2023 | 50k | $12k |
Sigma Planning | Sep 2023 | 20k | $4.9k |
Welch Group | Dec 2023 | 10k | $2.6k |
Front Row Advisors | Sep 2023 | 58.00 | $14.001200 |